ALS and Autoimmune Responses: New Research Links the Two
- this STAT News article discusses a recent study suggesting a potential autoimmune component to Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Here's a breakdown of...
- * Evidence of Autoimmunity: The study found that ALS patients exhibit stronger immune responses (specifically from T cells) to a protein fragment called C9orf72, a common genetic cause...
- In essence, the study provides compelling evidence supporting the idea that the immune system plays a meaningful role in ALS, possibly offering new avenues for research and treatment.
Summary of STAT News Article on ALS and Autoimmunity
this STAT News article discusses a recent study suggesting a potential autoimmune component to Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. Here’s a breakdown of the key takeaways:
* Evidence of Autoimmunity: The study found that ALS patients exhibit stronger immune responses (specifically from T cells) to a protein fragment called C9orf72, a common genetic cause of ALS, compared to healthy individuals. This suggests the body’s immune system is reacting to its own proteins.
* Not Definitive Proof: Researchers emphasize this doesn’t prove ALS is a classic autoimmune disease. It’s unclear if these self-reactive immune cells cause the disease or are a result of it. Further research is needed to determine the causal relationship.
* Potential for New Treatments: The findings open the door to exploring new treatment strategies that target the immune system to slow or halt ALS progression. Monitoring autoimmune cell activity could also help track disease progression.
* existing Knowledge: Scientists have long known about inflammation and T cell presence in the brains and spinal cords of ALS patients, fueling the hypothesis of an autoimmune link.
* Disease Overview: ALS is a fatal neurodegenerative disease affecting approximately 5 out of 100,000 people in the US. It leads to the loss of neurons controlling voluntary movement,ultimately impacting breathing and resulting in death within 2-5 years of diagnosis.
* IL-10 Connection: interestingly, the study also found that ALS patients predicted to live longer had T cells that produced higher levels of IL-10 when responding to C9orf72. IL-10 is a molecule that can suppress immune responses.
In essence, the study provides compelling evidence supporting the idea that the immune system plays a meaningful role in ALS, possibly offering new avenues for research and treatment.
The article also includes a link to another STAT News piece about a potential pre-symptomatic treatment for ALS and links to relevant research articles on PubMed and PMC.